Glycemicon AG
General Information
BounceWatch is an independent company data service, not affiliated with Glycemicon AG. To contact Glycemicon AG, visit glycemicon.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Glycemicon AG compare?
A PDF of Glycemicon AG and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Glycemicon AG soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Glycemicon AG
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | Fr.1.80M | - |
|
03 Apr 2018 |
| Series A | Fr.3.25M | - |
|
08 Feb 2017 |
| Pre Seed Round | Fr.100.00K | 1 |
|
22 Jan 2013 |
| Grant | Fr.10.00K | 1 |
|
09 Nov 2011 |
Glycemicon AG Alternatives & Competitors
View All Alternatives
Drugging the Undruggable with 1st-in-class RAR/RXR Nuclear Receptor Pathway Inhibitors. EFL Life Sci...
Prometheon Pharma has developed a transdermal platform technology called Topicon™, specifically form...
Carmot has been acquired by Roche in early 2024, making the company a member of the Roche Group.
FAQ About Glycemicon AG
Source: BounceWatch company record for Glycemicon AG, https://bouncewatch.com/company/glycemicon, updated 9 November 2024. When citing, please name BounceWatch and link this page.
